Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Cimetropium Bromide

Catalog No. T14966Cas No. 51598-60-8
Alias DA-3177

Cimetropium Bromide is a mAChR antagonist used for long-term treatment of irritable bowel syndrome.

Cimetropium Bromide

Cimetropium Bromide

Catalog No. T14966Alias DA-3177Cas No. 51598-60-8
Cimetropium Bromide is a mAChR antagonist used for long-term treatment of irritable bowel syndrome.
Pack SizePriceAvailabilityQuantity
2 mg$1405 days
25 mg$7666-8 weeks
50 mg$9966-8 weeks
100 mg$1,5406-8 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Cimetropium Bromide is a mAChR antagonist used for long-term treatment of irritable bowel syndrome.
In vitro
Cimetropium reduces the release of labeled acetylcholine (ACh) elicited by electrical field stimulation, particularly when muscarinic autoinhibition is blocked, as observed in superfusion experiments using preparations preloaded with labeled choline [2]. Furthermore, it exhibits a powerful antimuscarinic action by inhibiting the contraction of longitudinal muscle preparations. As a competitive antagonist, Cimetropium Bromide effectively counteracts muscarinic-mediated contractions in isolated colonic preparations from various species, demonstrating affinity values (pA2) between 7.41 and 7.82 [1].
In vivo
Cimetropium Bromide (10-100 μg/kg) counteracts colonic motor response to neostigmine administration (ID50: 27.9 μg/kg); both tonic and phasic components of contractile response are affected. Cimetropium is a potent inhibitor of large bowel motility evoked by both exogenous and endogenous stimuli when administered intravenously to conscious dogs provided with a colonic Thiry fistula. In a comparable range of doses (3-100μg/kg), the drug inhibits motor activity elicited by intraluminal distension [1].
AliasDA-3177
Chemical Properties
Molecular Weight438.36
FormulaC21H28BrNO4
Cas No.51598-60-8
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 50 mg/mL (114.06 mM), Sonication is recommended.
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM2.2812 mL11.4062 mL22.8123 mL114.0615 mL
5 mM0.4562 mL2.2812 mL4.5625 mL22.8123 mL
10 mM0.2281 mL1.1406 mL2.2812 mL11.4062 mL
20 mM0.1141 mL0.5703 mL1.1406 mL5.7031 mL
50 mM0.0456 mL0.2281 mL0.4562 mL2.2812 mL
100 mM0.0228 mL0.1141 mL0.2281 mL1.1406 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cimetropium Bromide | purchase Cimetropium Bromide | Cimetropium Bromide cost | order Cimetropium Bromide | Cimetropium Bromide chemical structure | Cimetropium Bromide in vivo | Cimetropium Bromide in vitro | Cimetropium Bromide formula | Cimetropium Bromide molecular weight